Member Info for tqhussain

https://www.google.co.uk/amp/s/www.smarteranalyst.com/new-blurbs/h-c-wainwright-reaffirms-their-buy-rating-on-pds-biotechnology-pdsb-2/amp/

Premarket up 10%

From RNS

“It is envisaged that the validation and initial commercialisation can be achieved largely from ProAxsis' existing resources.

Why Glycotest could do very well:
Hepatocellular carcinoma (HCC) is one of the deadliest health burdens worldwide. Most patients with HCC have dismal outcomes because of insufficient early diagnosis and few available treatment options for patients with advanced-stage HCC. https://jeccr.biomedcentral.com/

Glycotest is a early detection tool and its previous trials demonstrated superior results to current products/methods on the market. In Asia HCC is a growing problem, This helps explain why fosun pharm decided to invest in Glycotest. They must realise the need for such a product to help combat HCC.

PDSB is red hot at the moment.

I was busy with work and just got back to this nice surprise.

MC is still quite low with all that going on around the business.

PDSB presenting today:

Abstract Title: Phase II evaluation of the triple combination of PDS0101, M9241, and bintrafusp alfa in patients with HPV 16 positive malignancies.

Presenting Author: Julius Strauss, MD, National Cancer Institute
Session: Developmental Therapeutics—Immunotherapy
Date: June 7, 2021

So much going on at the moment with NSCI's holdings, H2 will be a news rich period.

PDSB shooting up and NSCI holding now worth more than £12m.

Pdsb up 12%

Yesterdays 'definitely buys' post and then the matching first names lol you could have pulled it off.

I still think Schroders should be out soon, there were some chunky sells as i mentioned yesterday.

Rajbury, is this you Mr Raj Chawla?

Looking at the trades from yesterday I would say they are pretty much out now, hopefully a holdings rns will confirm.

Up once again, 5% currently.

We now know our seller. Less than 5% to go if they continue to sell.

PDSB up 9%, if it holds then should see another blue day here tomorrow.

2-3 years ago Fosun committed a $10m investment for a 40% stake in Glycotest. The product trials should conclude in the USA this year and the Chinese are looking to go commercial with it this year. So, just to add to Crowfoots point, substantially more than £0k! :)

Dave, according to the MC near enough to zero.

You can have a look at the 2020 published accounts which give a fair value to each investment.

https://www.google.co.uk/amp/s/www.proactiveinvestors.co.uk/companies/amp/news/950567

Totally agree, I guess it’s hard to value ltd companies.

PDSB now up 11%